ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

In Brief: Calabresi: Rimer: Outstanding ”For NCAB Chair; board Should Maintain Strong Leadership Role

September 23, 1994

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

Group Chairmen Criticize NCI Budget Priorities

July 11, 2003

Skipper To Receive Bristol-Myers Award

March 14, 1980

DeCosse: Colorectal Screening Could Save 6,000 Lives Per Year

November 29, 1991